BridgeBio Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade BridgeBio Pharma 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BBIO
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development.
CEONeil Kumar
CEONeil Kumar
Employees730
Employees730
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded2015
Founded2015
Employees730
Employees730
BBIO Key Statistics
Market cap10.50B
Market cap10.50B
Price-Earnings ratio-13.41
Price-Earnings ratio-13.41
Dividend yield—
Dividend yield—
Average volume2.00M
Average volume2.00M
High today$55.49
High today$55.49
Low today$54.02
Low today$54.02
Open price$54.38
Open price$54.38
Volume1.36M
Volume1.36M
52 Week high$57.49
52 Week high$57.49
52 Week low$21.72
52 Week low$21.72
BBIO News
Nasdaq 1d
Interesting BBIO Put And Call Options For December 19thInvestors in BridgeBio Pharma Inc (Symbol: BBIO) saw new options begin trading this week, for the December 19th expiration. At Stock Options Channel , our Yield...
Analyst ratings
95%
of 20 ratingsBuy
95%
Hold
0%
Sell
5%
People also own
Based on the portfolios of people who own BBIO. This list is generated using Robinhood data, and it’s not a recommendation.